InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the full record of transactions filed by Otero Jose Manuel. Director active across 1 company, notably Lexeo Therapeutics, Inc.. Cumulatively, 3 filings have been published. Activity tracked since 12 June 2024. The latest transaction was disclosed on 14 March 2025 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
3 of 3 declarations